Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 171,554 | 88,021 | 70,759 | 52,519 | 49,274 |
| Cost of Goods | 103,610 | 59,418 | 51,278 | 32,514 | 19,700 |
| Gross Profit | 67,944 | 28,603 | 19,481 | 20,005 | 29,574 |
| Operating Expenses | 79,605 | 70,835 | 67,531 | 80,036 | 79,255 |
| Operating Income | -11,051 | -41,814 | -47,772 | -59,517 | -48,981 |
| Interest Expense | 7,907 | 5,961 | 3,108 | 3,042 | 1,536 |
| Other Income | 395 | 489 | 519 | 810 | 16 |
| Pre-tax Income | -18,563 | -47,286 | -50,361 | -61,749 | -50,501 |
| Income Tax | 81 | 64 | 139 | 101 | 100 |
| Net Income Continuous | -18,644 | -47,350 | -50,500 | -61,850 | -50,601 |
| Net Income | $-18,644 | $-47,350 | $-50,500 | $-61,850 | $-50,601 |
| EPS Basic Total Ops | -0.28 | -0.82 | -0.91 | -1.21 | -1.15 |
| EPS Basic Continuous Ops | -0.28 | -0.82 | -0.91 | -1.21 | -1.15 |
| EPS Diluted Total Ops | -0.28 | -0.82 | -0.91 | -1.21 | -1.15 |
| EPS Diluted Continuous Ops | -0.28 | -0.82 | -0.91 | -1.21 | -1.15 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.82 | -0.91 | -1.21 | -1.15 |
| EBITDA(a) | $-1,471 | $-32,939 | $-39,888 | $-53,107 | $-44,588 |